Lancet 368:16961705 Drucker DJ, Buse JB, Taylor K, Kendall DM, Trautmann M, Zhuang D, Porter L (2008) Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
I generally use a combination
Do not make any medication adjustments without consulting your doctor first
Acceptance is not approval it means the review clock starts and a decision date is assigned
Temporary hair shedding affects about 5-8% of people taking Retatrutide, typically starting 3-4 months into treatment
Answer a few quick questions and get your free Health Optimizer Profile: your stack, spending, data obsession, and longevity focus, scored against the community